Shanghai - Delayed Quote CNY

Kangmei Pharmaceutical Co., Ltd. (600518.SS)

Compare
1.7800 0.0000 (0.00%)
At close: 3:00 PM GMT+8
Loading Chart for 600518.SS
DELL
  • Previous Close 1.7800
  • Open 1.7800
  • Bid 1.7700 x --
  • Ask 1.7800 x --
  • Day's Range 1.7700 - 1.7900
  • 52 Week Range 1.6800 - 2.3300
  • Volume 63,037,742
  • Avg. Volume 106,959,602
  • Market Cap (intraday) 24.678B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 89.00
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 28, 2019
  • 1y Target Est --

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Shenzhen, China.

www.kangmei.com.cn

4,409

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600518.SS

View More

Performance Overview: 600518.SS

Trailing total returns as of 9/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

600518.SS
4.30%
SSE Composite Index
5.78%

1-Year Return

600518.SS
5.32%
SSE Composite Index
10.54%

3-Year Return

600518.SS
49.00%
SSE Composite Index
22.08%

5-Year Return

600518.SS
48.10%
SSE Composite Index
4.14%

Compare To: 600518.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600518.SS

View More

Valuation Measures

Annual
As of 9/2/2024
  • Market Cap

    24.68B

  • Enterprise Value

    24.12B

  • Trailing P/E

    89.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.99

  • Price/Book (mrq)

    3.49

  • Enterprise Value/Revenue

    4.85

  • Enterprise Value/EBITDA

    37.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.91%

  • Return on Assets (ttm)

    1.35%

  • Return on Equity (ttm)

    3.54%

  • Revenue (ttm)

    4.97B

  • Net Income Avi to Common (ttm)

    244.14M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    795.04M

  • Total Debt/Equity (mrq)

    3.33%

  • Levered Free Cash Flow (ttm)

    -399.31M

Research Analysis: 600518.SS

View More

Company Insights: 600518.SS

Research Reports: 600518.SS

View More

People Also Watch